AdvisorShares Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-116,501
Closed -$7.95M 237
2021
Q2
$7.95M Sell
116,501
-32,835
-22% -$2.14M 1.09% 13
2021
Q1
$10.4M Buy
149,336
+91,084
+156% +$7.01M 1.29% 15
2020
Q4
$4.47M Buy
58,252
+8,227
+16% +$617K 1.04% 12
2020
Q3
$3.74K Buy
50,025
+9,120
+22% +$608K 0.18% 9
2020
Q2
$2.58M Buy
40,905
+15,184
+59% +$835K 1.1% 8
2020
Q1
$1.08M Sell
25,721
-8,807
-26% -$404K 0.94% 16
2019
Q4
$1.57M Buy
+34,528
New +$1.63M 0.98% 17

Other funds holding ARNA

AdvisorShares Investments's ARNA Position: Q3 2021 in Review

AdvisorShares Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 116,501 shares — an estimated $7.95M sold.

AdvisorShares Investments first reported a position in ARNA in Q4 2019 and held it in 7 quarters. The position peaked at $10.4M in Q1 2021. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • AdvisorShares Investments reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • AdvisorShares Investments sold 116,501 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $7.95M.
  • AdvisorShares Investments first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 7 quarters.
  • AdvisorShares Investments's Arena Pharmaceuticals Inc position peaked at $10.4M in Q1 2021.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on AdvisorShares Investments's 13F filing for Q3 2021, filed 4 Nov 2021.